[The use of oxytocin and prostaglandin in pregnancies after cesarean delivery or uterine surgery].
OBJECTIVE
Evaluation of risks involved with the use of oxytocin and prostaglandin in pregnancies after caesarean delivery or uterine surgery.


METHODS
This study involved 267 pregnant women who underwent caesarean delivery or gynaecological surgery within the uterus (myomectomy or Strassmann corrective surgery). Oxytocin and prostaglandin was used to induce uterine contraction in these women. We analysed their delivery methods and the frequency of complications like uterine rupture and rupture of past caesarean scar.


RESULTS
Uterine rupture occurred in one women had history of caesarean delivery (0.5%), and rupture past history of caesarean scar occurred in eight women (3.5%) who previously underwent caesarean delivery. Complications were not found in women with past history of myomectomy or Strassmann Corrective surgery. We did not observe an increase in complications among women who received prostaglandin compared to those who received oxytocin.


CONCLUSIONS
1. Cardiotocographic monitor during labour reduces the risk of uterine rupture and rupture of past caesarean scar in pregnant women with past history of caesarean delivery or other uterine surgeries. 2. The use of prostaglandin in comparison to oxytocin does not increase complications in women with past history of uterine surgery. 3. The choice of delivery method in pregnant women with past history of uterine should be individualised.
Tomiałowicz
M
M
Kliniki Rozrodczości i Połoznictwa AM we Wrocławiu.
Florjański
J
J
Zimmer
M
M
D002585:Cesarean Section; D005260:Female; D006801:Humans; D010121:Oxytocin / Q000627:therapeutic use*; D011247:Pregnancy; D011453:Prostaglandins / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors; D014599:Uterus / Q000601:surgery*
D011453:Prostaglandins; D010121:Oxytocin
Zastosowanie oksytocyny i prostaglandyn u ciezarnych po przebytych cieciach cesarskich oraz operacjach w obrebie trzonu macicy.